Trypanocidal Activity of Four Sesquiterpene Lactones Isolated from Asteraceae Species
Orlando G. Elso,
Augusto E. Bivona,
Andrés Sanchez Alberti,
Natacha Cerny,
Lucas Fabian,
Celina Morales,
César A. N. Catalán,
Emilio L. Malchiodi,
Silvia I. Cazorla,
Valeria P. Sülsen
Affiliations
Orlando G. Elso
Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET–Universidad de Buenos Aires, Junín 956 2° floor, Buenos Aires 1113, Argentina
Augusto E. Bivona
Cátedra de Inmunología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 4° floor, Buenos Aires 1113, Argentina
Andrés Sanchez Alberti
Cátedra de Inmunología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 4° floor, Buenos Aires 1113, Argentina
Natacha Cerny
Instituto de Ecología y Desarrollo Sustentable (INEDES), CONICET—Universidad Nacional de Luján, Ruta 5 y Avenida Constitución, Luján 6700, Argentina
Lucas Fabian
Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET–Universidad de Buenos Aires, Junín 956 2° floor, Buenos Aires 1113, Argentina
Celina Morales
Departamento de Patología, Instituto de Fisiopatología Cardiovascular, Universidad de Buenos Aires, Facultad de Medicina, Buenos Aires 1113, Argentina
César A. N. Catalán
Instituto de Química del Noroeste—CONICET (INQUINOA), CONICET—Universidad Nacional de Tucumán, Ayacucho 471, San Miguel de Tucumán T4000INI, Argentina
Emilio L. Malchiodi
Cátedra de Inmunología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 4° floor, Buenos Aires 1113, Argentina
Silvia I. Cazorla
Instituto de Microbiología y Parasitología Médica—CONICET (IMPaM), Facultad de Medicina, CONICET—Universidad de Buenos Aires, Paraguay 2155. 13° floor, Buenos Aires C1121ABG, Argentina
Valeria P. Sülsen
Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET–Universidad de Buenos Aires, Junín 956 2° floor, Buenos Aires 1113, Argentina
The sesquiterpene lactones eupatoriopicrin, estafietin, eupahakonenin B and minimolide have been isolated from Argentinean Astearaceae species and have been found to be active against Trypanosoma cruzi epimastigotes. The aim of this work was to evaluate the activity of these compounds by analyzing their effect against the stages of the parasites that are infective for the human. Even more interesting, we aimed to determine the effect of the most active and selective compound on an in vivo model of T. cruzi infection. Eupatoriopicrin was the most active against amastigotes and tripomastigotes (IC50 = 2.3 µg/mL, and 7.2 µg/mL, respectively) and displayed a high selectivity index. This compound was selected to study on an in vivo model of T. cruzi infection. The administration of 1 mg/kg/day of eupatoriopicrin for five consecutive days to infected mice produced a significant reduction in the parasitaemia levels in comparison with non-treated animals (area under parasitaemia curves 4.48 vs. 30.47, respectively). Skeletal muscular tissues from eupatopicrin-treated mice displayed only focal and interstitial lymphocyte inflammatory infiltrates and small areas of necrotic; by contrast, skeletal tissues from T. cruzi infected mice treated with the vehicle showed severe lymphocyte inflammatory infiltrates with necrosis of the adjacent myocytes. The results indicate that eupatoriopicrin could be considered a promising candidate for the development of new therapeutic agents for Chagas disease.